Get 50% OFF This Monsoon!
Transpek Industry
No Data Available
No Stocks
Unlock Smart Score
See Detailed Analysis & Insights
Unlock Insights
See Detailed Analysis & Insights
No Research Report
ROE
Avg ROE (3 Yrs) : NaN%
ROCE
Avg ROCE (3 Yrs) : NaN%
ROA
Avg ROA (3 Yrs) : NaN%
NPM
Avg NPM (3 Yrs) : NaN%
No Data Available
Unlock Management Data
See Detailed Analysis & Insights
Transpek Industry Limited is a leading global supplier for chlorinated products to various industry sectors ranging from Pharmaceuticals, Agrochemicals and dyes to pigments. The Company has an excellent experience in manufacturing of products using chlorinated chemistry presenting unending opportunities for supply of intermediates and speciality chemicals suitable for multiple applications. Presently, the Company is is into the manufacturing and export of a range of chemicals servicing the requirements of customers from a diverse range of industries - Textiles, Pharmaceuticals, Agrochemicals, Advanced Polymers, etc.
Established in October, 1965, Transpek Industry Limited (TIL) went public in Sep.'78. It started with the manufacture of acrylic plastic sheets at its plant at Atladra (Vadodra district), Gujarat. In 1969, it discontinued manufacturing acrylic sheets and started manufacturing chemicals.
TIL started off with products like sodium hexameta phosphate, sodium tripoly phosphate, phosphoric acid, etc. In 1978, it expanded to manufacture sodium hydrosulphite (hydro), sodium formaldehyde sulphoxylate (safolite), thionyl chloride and sulphur dioxide, most of these being manufactured for the first time in India. TIL entered the global scenario in 1987 and is a government-recognised Export House.
The company manufactures a wide range of chemicals and intermediates which include sodium hydrosulphite, sodium formaldehyde sulphoxylate, zinc formaldehyde sulphoxylate (safolin), thionyl chloride, sulphur dichloride, rubber accelerators and the metals recovered include copper and zinc. It is the world's largest manufacturer of safolite and safolin and also India's only exporter of thionyl chloride and chloro acetyl chloride.
TIL expanded its capacities for rubber chemicals, sodium hydrosulphite and thionyl chloride and had set up a joint venture in China for thionyl chloride.In 1995-96, a new sulphur-di-oxide recovery and filling station was commissioned conforming to CCOE requirement. In 1996-97, it increased the installed capacity of Chlorinated Compounds to 16,200 tpa and in 1998-99, of rubber and related chemicals to 1,272 MT.
A MOU has been signed by the Company, its subsidiary Transpek Metals and Oxides Limited (TMOL) and SILOX. The Company has disinvested its holding in the above company from 39% to 14.93% to Excel Industries Ltd. During 2001-02 the Sulphoxylates Business of Transpek Industry was transferred to Transpek Metals and Oxides Ltd.
The company has expanded the installed capacity of Chlorinated Compound during the year 2003-04 by 2830 Tonnes and with this expansion,the total capacity has risen to 19700 Tonnes.
During the year 2004-05, the Company commissioned the business of Acid Chloride products. The Company's wholly owned subsidiary company viz. Transpek Marketing Ltd, was merged with Company and consequently, all its assets and liabilities were transferred to and vested in the Company through Scheme of Arrangement implemented effective from April 1, 2004, the Appointed Date during FY 2004-05.
In 2005 - 06, the Company improved technology for the manufacture of Thionyl Chloride ('TC') and as a result, increased the installed capacity of TC to19500 TPA. During year 2006-07, the installed capacity of Thionyl Chloride plant increased to 23% per annum. Continuous process improvements resulted in reduction in costs and in effluent and by-products generation. De-bottle-necking of the SO3 plant resulted in an increase in its capacity to 12% p.a. By strengthening R&D activities, three new products were added to the product slate of the Company during the year.
A wholly-owned subsidiary called Transpek Industry (Europe) Ltd. was established in the United Kingdom effective on April 24, 2008. During FY 2008-09, production was increased by capacity addition due to de-bottlenecking, efficiency improvement, recovery of products from residue, implementing newer techniques to handle process and adopting new techniques to convert by-products into value added products. Resultantly, these measures helped in increasing production, effecting saving in consumption of power and maintenance in market share.
The Company acquired 50% holding in a small pharma company, Sam Finechem Ltd (SFL) and accordingly, it deemed to be a subsidiary Company effective from 2010-11. During FY 2014-15, the Company divested its investments from Sam Fine O Chem Limited (SFOCL) and hence, SFOCL ceased to be the Subsidiary of the Company w.e.f. 03.01.2015. Later during FY 2019-20, the Company incorporated a Wholly Owned Subsidiary viz. Transpek Creative Chemistry Private Limited (TCCPL) on 6th January, 2020.
Transpek Industry share price reflects investor sentiment toward the company and is impacted by various factors such as financial performance, market trends, and economic conditions. Share price is an indicator which shows the current value of the company's shares at which buyers or sellers can transact.
Market capitalization of Transpek Industry indicates the total value of its outstanding shares. Marketcap is calculated by multiplying share price and outstanding shares of the company. It is a helpful metric for assessing the company's size and market Valuation. It also helps investors understand how Transpek Industry is valued compared to its competitors.
Transpek Industry PE ratio helps investors understand what is the market value of each stock compared to Transpek Industry 's earnings. A PE ratio higher than the average industry PE could indicate an overvaluation of the stock, whereas a lower PE compared to the average industry PE could indicate an undervaluation.
The PEG ratio of Transpek Industry evaluates its PE ratio in relation to its growth rate. A PEG ratio of 1 indicates a fair value, a PEG ratio of less than 1 indicates undervaluation, and a PEG ratio of more than 1 indicates overvaluation.
Return on Equity (ROE) measures how effectively Transpek Industry generates profit from shareholders' equity. A higher ROE of more than 20% indicates better financial performance in terms of profitability.
Return on Capital Employed (ROCE) evaluates the profitability of Transpek Industry in relation to its capital employed. In simple terms, ROCE provides insight to investors as to how well the company is utilizing the capital deployed. A high ROCE of more than 20% shows that the business is making profitable use of its capital.
Total debt of Transpek Industry shows how much the company owes to either banks or individual creditors. In simple terms, this is the amount the company has to repay. Total debt can be a very useful metric to show the financial health of the company. Total debt more than equity is considered to be a bad sign.
The Debt-to-Equity (DE) ratio of Transpek Industry compares its total debt to shareholders' equity. A higher Debt to Equity ratio could indicate higher financial risk, while a lower ratio suggests that the company is managing its debt efficiently.
CAGR shows the consistent growth rate of Transpek Industry over a specific period, whether it is over a month, a year, or 10 years. It is a key metric to evaluate the company’s long-term growth potential. Main metrics for which CAGR is calculated are net sales, net profit, operating profit, and stock returns.
Technical analysis of Transpek Industry helps investors get an insight into when they can enter or exit the stock. Key components of Transpek Industry Technical Analysis include:
There are usually multiple support levels, but the main support levels for a stock are S1, S2, S3. Support levels indicate price points where stock might get support from buyers, helping the stock stop falling and rise.
There are usually multiple resistance levels, but the main resistance levels for a stock are R1, R2, R3. Resistance levels represent price points where Transpek Industry shares often struggle to rise above due to selling pressure.
Dividends refer to the portion of the company’s profits distributed to its shareholders. Dividends are typically paid out in cash and reflect Transpek Industry ’s financial health and profitability.
Bonus shares are usually given by companies to make the stock more affordable, increase liquidity, boost investor confidence, and more.
Stock split increases the number of its outstanding shares by dividing each existing share into multiple shares. When the company offers a stock split, the face value of the stock reduces in the same proportion as the split ratio.
The financials of Transpek Industry provide a complete view to investors about its net sales, net profit, operating profits, expenses, and overall financial health. Investors can analyze financial data to assess the company’s stability and also understand how the company has been growing financially.
The profit and loss statement of Transpek Industry highlights its net sales, net profit, total expenditure, and operating profits in the current financial year. This Profit and Loss statement is crucial for evaluating the profitability and financial stability of Transpek Industry .
The balance sheet presents a snapshot of Transpek Industry ’s assets, liabilities, and equity of shareholders, providing insights into the financials of the company.
Cashflow statements track the company's cash inflows and outflows over a period. It is an essential tool for understanding how well the company manages its liquidity and finances.